MedWatch·Financial report·Business & finance·7d agoDanske Bank sees promising outlook for Demant after strong Q1Investor confidence in Demant signals continued R&D and commercial momentum for Oticon products, which may shape future device availability and competition in the hearing aid market.
MedWatch·Financial report·Business & finance·10d agoDanske Bank sees potential focus on Demant’s miniature product launch and GN’s sale to Amplifon in interim reportA potential GN–Amplifon deal and Demant's product pipeline are market-shaping events that could alter competitive dynamics, pricing, and product availability across audiology clinics globally.＋Save
